{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:34:24Z","timestamp":1788942864616,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12149-026-02174-4","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:36:53Z","timestamp":1776335813000},"page":"707-722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Visceral technetium-99\u00a0m-labeled pyrophosphate uptake in patients with wild-type transthyretin cardiac amyloidosis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3826-3941","authenticated-orcid":false,"given":"Koji","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Iwamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyasu","family":"Hiratsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohei","family":"Kitazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuharu","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroe","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Sakaue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuji","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"2174_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.carpath.2015.07.008","volume":"24","author":"JJ Maleszewski","year":"2015","unstructured":"Maleszewski JJ. Cardiac amyloidosis: pathology, nomenclature, and typing. Cardiovasc Pathol. 2015;24:343\u201350. https:\/\/doi.org\/10.1016\/j.carpath.2015.07.008.","journal-title":"Cardiovasc Pathol"},{"key":"2174_CR2","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","volume":"142","author":"MM Kittleson","year":"2020","unstructured":"Kittleson MM, Maurer MS, Ambardekar AV, Bullock-Palmer RP, Chang PP, Eisen HJ, et al. Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association. Circulation. 2020;142:e7-22. https:\/\/doi.org\/10.1161\/CIR.0000000000000792.","journal-title":"Circulation"},{"key":"2174_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jacep.2020.01.004","volume":"6","author":"S Giancaterino","year":"2020","unstructured":"Giancaterino S, Urey MA, Darden D, Hsu JC. Management of arrhythmias in cardiac amyloidosis. JACC Clin Electrophysiol. 2020;6:351\u201361. https:\/\/doi.org\/10.1016\/j.jacep.2020.01.004.","journal-title":"JACC Clin Electrophysiol"},{"key":"2174_CR4","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","volume":"42","author":"P Garcia-Pavia","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021;42:1554\u201368. https:\/\/doi.org\/10.1093\/eurheartj\/ehab072.","journal-title":"Eur Heart J"},{"key":"2174_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/13506129.2024.2405948","volume":"31","author":"JN Buxbaum","year":"2024","unstructured":"Buxbaum JN, Eisenberg DS, F\u00e4ndrich M, McPhail ED, Merlini G, Saraiva MJM, et al. Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid. 2024;31:249\u201356. https:\/\/doi.org\/10.1080\/13506129.2024.2405948.","journal-title":"Amyloid"},{"key":"2174_CR6","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jacc.2024.01.010","volume":"83","author":"E Gonzalez-Lopez","year":"2024","unstructured":"Gonzalez-Lopez E, McPhail ED, Salas-Anton C, Dominguez F, Gertz MA, Dispenzieri A, et al. Histological typing in patients with cardiac amyloidosis: JACC review topic of the week. J Am Coll Cardiol. 2024;83:1085\u201399. https:\/\/doi.org\/10.1016\/j.jacc.2024.01.010.","journal-title":"J Am Coll Cardiol"},{"key":"2174_CR7","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","volume":"81","author":"MM Kittleson","year":"2023","unstructured":"Kittleson MM, Ruberg FL, Ambardekar AV, Brannagan TH, Cheng RK, Writing Committee, et al. 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023;81:1076\u2013126. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.022.","journal-title":"J Am Coll Cardiol"},{"key":"2174_CR8","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1016\/j.jcmg.2019.06.023","volume":"12","author":"M Fontana","year":"2019","unstructured":"Fontana M, \u0106orovi\u0107 A, Scully P, Moon JC. Myocardial amyloidosis: the exemplar interstitial disease. JACC Cardiovasc Imaging. 2019;12:2345\u201356. https:\/\/doi.org\/10.1016\/j.jcmg.2019.06.023.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2174_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000506696","volume":"143","author":"MM Picken","year":"2020","unstructured":"Picken MM. The pathology of amyloidosis in classification: a review. Acta Haematol. 2020;143:322\u201334. https:\/\/doi.org\/10.1159\/000506696.","journal-title":"Acta Haematol"},{"key":"2174_CR10","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","volume":"15","author":"DF Hutt","year":"2014","unstructured":"Hutt DF, Quigley AM, Page J, Hall ML, Burniston M, Gopaul D, et al. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Eur Heart J Cardiovasc Imaging. 2014;15:1289\u201398. https:\/\/doi.org\/10.1093\/ehjci\/jeu107.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2174_CR11","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1007\/s12350-021-02890-6","volume":"29","author":"K Takahashi","year":"2022","unstructured":"Takahashi K, Sasaki D, Yamashita M, Sakaue T, Enomoto D, Morioka H, et al. Amyloid deposit corresponds to technetium-99m-pyrophosphate accumulation in abdominal fat of patients with transthyretin cardiac amyloidosis. J Nucl Cardiol. 2022;29:3126\u201336. https:\/\/doi.org\/10.1007\/s12350-021-02890-6.","journal-title":"J Nucl Cardiol"},{"key":"2174_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/RLU.0000000000004397","volume":"48","author":"K Takahashi","year":"2023","unstructured":"Takahashi K, Hiratsuka Y, Sasaki D, Sakaue T, Enomoto D, Morioka H, et al. 99mTc-pyrophosphate scintigraphy can image tracer uptake in skeletal trunk muscles of transthyretin cardiac amyloidosis. Clin Nucl Med. 2023;48:18\u201324. https:\/\/doi.org\/10.1097\/RLU.0000000000004397.","journal-title":"Clin Nucl Med"},{"key":"2174_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/13506129.2023.2235881","volume":"31","author":"K Takahashi","year":"2024","unstructured":"Takahashi K, Hiratsuka Y, Iwamura T, Sasaki D, Yamamura N, Kitazawa S, et al. Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis. Amyloid. 2024;31:12\u201321. https:\/\/doi.org\/10.1080\/13506129.2023.2235881.","journal-title":"Amyloid"},{"key":"2174_CR14","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1253\/circj.CJ-20-0110","volume":"84","author":"H Kitaoka","year":"2020","unstructured":"Kitaoka H, Izumi C, Izumiya Y, Inomata T, Ueda M, Kubo T, et al. JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis. Circ J. 2020;84:1610\u201371. https:\/\/doi.org\/10.1253\/circj.CJ-20-0110.","journal-title":"Circ J"},{"key":"2174_CR15","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/modpathol.2011.117","volume":"24","author":"M Ueda","year":"2011","unstructured":"Ueda M, Horibata Y, Shono M, Misumi Y, Oshima T, Su Y, et al. Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study. Mod Pathol. 2011;24:1533\u201344. https:\/\/doi.org\/10.1038\/modpathol.2011.117.","journal-title":"Mod Pathol"},{"key":"2174_CR16","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.amjcard.2014.02.030","volume":"113","author":"NM Fine","year":"2014","unstructured":"Fine NM, Arruda-Olson AM, Dispenzieri A, Zeldenrust SR, Gertz MA, Kyle RA, et al. Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis. Am J Cardiol. 2014;113:1723\u20137. https:\/\/doi.org\/10.1016\/j.amjcard.2014.02.030.","journal-title":"Am J Cardiol"},{"key":"2174_CR17","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1253\/circj.CJ-22-0118","volume":"86","author":"M Nishi","year":"2022","unstructured":"Nishi M, Takashio S, Morioka M, Fujiyama A, Nakashima N, Hirakawa K, et al. Extracardiac biopsy sensitivity in transthyretin amyloidosis cardiomyopathy patients with positive 99mTc-labeled pyrophosphate scintigraphy findings. Circ J. 2022;86:1113\u201320. https:\/\/doi.org\/10.1253\/circj.CJ-22-0118.","journal-title":"Circ J"},{"key":"2174_CR18","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.mayocp.2020.06.029","volume":"95","author":"S Dasari","year":"2020","unstructured":"Dasari S, Theis JD, Vrana JA, Rech KL, Dao LN, Howard MT, et al. Amyloid typing by mass spectrometry in clinical practice: a comprehensive review of 16,175 samples. Mayo Clin Proc. 2020;95:1852\u201364. https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.029.","journal-title":"Mayo Clin Proc"},{"key":"2174_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/pin.13041","volume":"71","author":"R Abe","year":"2021","unstructured":"Abe R, Katoh N, Takahashi Y, Takasone K, Yoshinaga T, Yazaki M, et al. Distribution of amyloidosis subtypes based on tissue biopsy site\u2014consecutive analysis of 729 patients at a single amyloidosis center in Japan. Pathol Int. 2021;71:70\u20139. https:\/\/doi.org\/10.1111\/pin.13041.","journal-title":"Pathol Int"},{"key":"2174_CR20","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.2169\/internalmedicine.2742-23","volume":"63","author":"K Takahashi","year":"2024","unstructured":"Takahashi K, Iwamura T, Hiratsuka Y, Sasaki D, Yamamura N, Ueda M, et al. A gluteus medius muscle biopsy to confirm amyloid transthyretin deposition in wild-type transthyretin cardiac amyloidosis: a report of two cases. Intern Med. 2024;63:1575\u201384. https:\/\/doi.org\/10.2169\/internalmedicine.2742-23.","journal-title":"Intern Med"},{"key":"2174_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/nm9.0000000000000025","volume":"2","author":"K Takahashi","year":"2025","unstructured":"Takahashi K, Sasaki D, Yamamura N, Iwamura T, Hiratsuka Y, Yamamoto S, et al. Extracardiac tracer uptake on technetium-99m-labeled pyrophosphate scintigraphy in patients with non-transthyretin cardiac amyloidosis. Clin Nucl Med Open. 2025;2:e0025. https:\/\/doi.org\/10.1097\/nm9.0000000000000025.","journal-title":"Clinical Nuclear Medicine Open"},{"key":"2174_CR22","doi-asserted-by":"publisher","DOI":"10.1161\/HCI.0000000000000029","volume":"14","author":"S Dorbala","year":"2021","unstructured":"Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging. Circ Cardiovasc Imaging. 2021;14:e000029. https:\/\/doi.org\/10.1161\/HCI.0000000000000029.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2174_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.17996\/anc.25-001","volume":"11","author":"T Kudo","year":"2025","unstructured":"Kudo T, Kuji I, Nakajima K, Fukushima K, Maruno H, Iguchi N, et al. Nuclear medicine imaging for the diagnosis of ATTR cardiac amyloidosis: report of Japanese Society of Nuclear Cardiology Working Group. Ann Nucl Cardiol. 2025;11:3\u201312. https:\/\/doi.org\/10.17996\/anc.25-001.","journal-title":"Ann Nucl Cardiol"},{"key":"2174_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12350-022-02960-3","volume":"30","author":"L Kessler","year":"2023","unstructured":"Kessler L, Fragoso Costa P, Kersting D, Jentzen W, Weber M, L\u00fcdike P, et al. Quantitative 99mTc-DPD-SPECT\/CT assessment of cardiac amyloidosis. J Nucl Cardiol. 2023;30:101\u201311. https:\/\/doi.org\/10.1007\/s12350-022-02960-3.","journal-title":"J Nucl Cardiol"},{"key":"2174_CR25","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1007\/s12350-021-02857-7","volume":"29","author":"S Watanabe","year":"2022","unstructured":"Watanabe S, Nakajima K, Wakabayashi H, Yoneyama H, Yoshida S, Komatsu J, et al. Volumetric evaluation of 99mTc-pyrophosphate SPECT\/CT for transthyretin cardiac amyloidosis: methodology and correlation with cardiac functional parameters. J Nucl Cardiol. 2022;29:3102\u201310. https:\/\/doi.org\/10.1007\/s12350-021-02857-7.","journal-title":"J Nucl Cardiol"},{"key":"2174_CR26","unstructured":"Senda K, Imaeda T. Bone scintigraphy with 99mTc-pyrophosphate. Rinsho Hoshasen. 1975;20:301\u20138."},{"key":"2174_CR27","unstructured":"Mallinckrodt Pharmaceuticals. Technescan PYP kit for the preparation of technetium Tc99m pyrophosphate injection; published 2017. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/017538s019lbl.pdf. Accessed Sep 23 2025."},{"key":"2174_CR28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transplant"},{"key":"2174_CR29","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/ejhf.3354","volume":"26","author":"C Nitsche","year":"2024","unstructured":"Nitsche C, Ioannou A, Patel RK, Razvi Y, Porcari A, Rauf MU, et al. Expansion of the National Amyloidosis Centre staging system to detect early mortality in transthyretin cardiac amyloidosis. Eur J Heart Fail. 2024;26:2008\u201312. https:\/\/doi.org\/10.1002\/ejhf.3354.","journal-title":"Eur J Heart Fail"},{"key":"2174_CR30","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1253\/circj.CJ-22-0032","volume":"86","author":"S Ishihara","year":"2022","unstructured":"Ishihara S, Hiramitsu S, Kanaoka K, Taki M, Nakagawa H, Ueda T, et al. New conversion formula between B-type natriuretic peptide and N-terminal-pro-B-type natriuretic peptide\u2014analysis from a multicenter study. Circ J. 2022;86:2010\u20138. https:\/\/doi.org\/10.1253\/circj.CJ-22-0032.","journal-title":"Circ J"},{"key":"2174_CR31","doi-asserted-by":"publisher","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29:277\u2013314. https:\/\/doi.org\/10.1016\/j.echo.2016.01.011.","DOI":"10.1016\/j.echo.2016.01.011"},{"key":"2174_CR32","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00259-016-3415-4","volume":"43","author":"T Van den Wyngaert","year":"2016","unstructured":"Van den Wyngaert T, Strobel K, Kampen WU, Kuwert T, van der Bruggen W, Mohan HK, et al. The EANM practice guidelines for bone scintigraphy. Eur J Nucl Med Mol Imaging. 2016;43:1723\u201338. https:\/\/doi.org\/10.1007\/s00259-016-3415-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2174_CR33","doi-asserted-by":"publisher","unstructured":"Khor YM, Cuddy SAM, Singh V, Falk RH, Di Carli MF, Dorbala S. 99mTc bone-avid tracer cardiac scintigraphy: role in noninvasive diagnosis of transthyretin cardiac amyloidosis. Radiology. 2023;306:e221082. https:\/\/doi.org\/10.1148\/radiol.221082.","DOI":"10.1148\/radiol.221082"},{"key":"2174_CR34","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1007\/s12350-020-02273-3","volume":"27","author":"S Bokhari","year":"2020","unstructured":"Bokhari S, Cerqueira MD. Tc-99m-PYP imaging for cardiac amyloidosis: defining the best protocol before the flood gates burst. J Nucl Cardiol. 2020;27:1816\u20139. https:\/\/doi.org\/10.1007\/s12350-020-02273-3.","journal-title":"J Nucl Cardiol"},{"key":"2174_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2967\/jnmt.123.265416","volume":"51","author":"EJ Schockling","year":"2023","unstructured":"Schockling EJ, Farrell MB, Embry-Dierson M, Warren J, Jerome S. Cardiac amyloidosis imaging, part 2: quantification and technical considerations. J Nucl Med Technol. 2023;51:90\u20138. https:\/\/doi.org\/10.2967\/jnmt.123.265416.","journal-title":"J Nucl Med Technol"},{"key":"2174_CR36","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.jaccas.2021.02.015","volume":"3","author":"K Takahashi","year":"2021","unstructured":"Takahashi K, Sasaki D, Sakaue T, Enomoto D, Uemura S, Okura T, et al. Extracardiac accumulation of technetium-99m-pyrophosphate in transthyretin cardiac amyloidosis. JACC Case Rep. 2021;3:1069\u201374. https:\/\/doi.org\/10.1016\/j.jaccas.2021.02.015.","journal-title":"JACC: Case Reports"},{"key":"2174_CR37","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.jcmg.2020.03.020","volume":"13","author":"PR Scully","year":"2020","unstructured":"Scully PR, Morris E, Patel KP, Treibel TA, Burniston M, Klotz E, et al. DPD quantification in cardiac amyloidosis: A novel imaging biomarker. JACC Cardiovasc Imaging. 2020;13:1353\u201363. https:\/\/doi.org\/10.1016\/j.jcmg.2020.03.020.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2174_CR38","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s00259-022-06028-9","volume":"50","author":"JC Dickson","year":"2023","unstructured":"Dickson JC, Armstrong IS, Gabi\u00f1a PM, Denis-Bacelar AM, Krizsan AK, Gear JM, et al. EANM practice guideline for quantitative SPECT-CT. Eur J Nucl Med Mol Imaging. 2023;50:980\u201395. https:\/\/doi.org\/10.1007\/s00259-022-06028-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2174_CR39","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1007\/s00259-020-04753-7","volume":"47","author":"N Malka","year":"2020","unstructured":"Malka N, Abulizi M, Kharoubi M, Oghina S, Galat A, Le Bras F, et al. Extracardiac soft tissue uptake, evidenced on early 99mTc-HMDP SPECT\/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value. Eur J Nucl Med Mol Imaging. 2020;47:2396\u2013406. https:\/\/doi.org\/10.1007\/s00259-020-04753-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2174_CR40","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1007\/s12350-023-03310-7","volume":"30","author":"N Chan","year":"2023","unstructured":"Chan N, Einstein AJ, Griffin JM, Rosenblum H, Teruya S, Cuomo M, et al. Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases. J Nucl Cardiol. 2023;30:2531\u20139. https:\/\/doi.org\/10.1007\/s12350-023-03310-7.","journal-title":"J Nucl Cardiol"},{"key":"2174_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03407-3","volume":"19","author":"C Karam","year":"2024","unstructured":"Karam C, Moffit C, Summers C, Merkel MP, Kochman FM, Weijers L, et al. The journey to diagnosis of wild-type transthyretin-mediated (ATTRwt) amyloidosis: a path with multisystem involvement. Orphanet J Rare Dis. 2024;19:419. https:\/\/doi.org\/10.1186\/s13023-024-03407-3.","journal-title":"Orphanet J Rare Dis"},{"key":"2174_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0726-x","volume":"13","author":"Y Sekijima","year":"2018","unstructured":"Sekijima Y, Ueda M, Koike H, Misawa S, Ishii T, Ando Y. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Orphanet J Rare Dis. 2018;13:6. https:\/\/doi.org\/10.1186\/s13023-017-0726-x.","journal-title":"Orphanet J Rare Dis"},{"key":"2174_CR43","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","volume":"73","author":"FL Ruberg","year":"2019","unstructured":"Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73:2872\u201391. https:\/\/doi.org\/10.1016\/j.jacc.2019.04.003.","journal-title":"J Am Coll Cardiol"},{"key":"2174_CR44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jns.2008.02.019","volume":"270","author":"Y Kato-Motozaki","year":"2008","unstructured":"Kato-Motozaki Y, Ono K, Shima K, Morinaga A, Machiya T, Nozaki I, et al. Epidemiology of familial amyloid polyneuropathy in Japan: identification of a novel endemic focus. J Neurol Sci. 2008;270:133\u201340. https:\/\/doi.org\/10.1016\/j.jns.2008.02.019.","journal-title":"J Neurol Sci"},{"key":"2174_CR45","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00415-017-8640-7","volume":"265","author":"T Yamashita","year":"2018","unstructured":"Yamashita T, Ueda M, Misumi Y, Masuda T, Nomura T, Tasaki M, et al. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan. J Neurol. 2018;265:134\u201340. https:\/\/doi.org\/10.1007\/s00415-017-8640-7.","journal-title":"J Neurol"},{"key":"2174_CR46","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/RLU.0000000000005521","volume":"49","author":"K Takahashi","year":"2024","unstructured":"Takahashi K, Iwamura T, Sasaki D, Ueda M, Okura T. Wild-type transthyretin amyloidosis with 99mTc-PYP uptake in the extracardiac soft tissues but not in the myocardium. Clin Nucl Med. 2024;49:1136\u20138. https:\/\/doi.org\/10.1097\/RLU.0000000000005521.","journal-title":"Clin Nucl Med"},{"key":"2174_CR47","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.84759","volume":"17","author":"K Takahashi","year":"2025","unstructured":"Takahashi K, Yoshida S, Ueda M, Uemura S, Inoue K. Wild-type transthyretin amyloid depositions in the subcutaneous fat and skeletal muscles of a nonagenarian who had heart failure with preserved ejection fraction and no myocardial technetium-99m-labeled pyrophosphate uptake. Cureus. 2025;17:e84759. https:\/\/doi.org\/10.7759\/cureus.84759.","journal-title":"Cureus"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02174-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02174-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02174-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:19:34Z","timestamp":1779956374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-026-02174-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2174"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02174-4","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Conflict of interest\u00a0","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The corresponding author has collected the ICMJE form for disclosure of potential conflicts of interest from all authors. The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}]}}